NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER-CELL FUNCTIONS IN HODGKINS-DISEASE

被引:10
|
作者
RAJARAM, N
TATAKE, RJ
ADVANI, SH
GANGAL, SG
机构
[1] CANC RES INST,DIV IMMUNOL,BOMBAY 400012,INDIA
[2] TATE MEM HOSP,TATA MEM CTR,BOMBAY 400012,INDIA
关键词
D O I
10.1038/bjc.1990.261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the natural killer (NK) and lymphokine activated killer (LAK) cell activities in peripheral blood lymphocytes (PBL) from untreated patients with Hodgkin’s disease (HD) and from healthy donors. The frequency of LAK cell precursors was also studied using limiting dilution analysis (LDA). About 75% of the HD patients had normal NK activity. There was a higher percentage of low NK responders (mean percent NK activity of healthy donors - 2 SD) in patients with lymphocyte depletion histologic grade of the disease and those who were in clinical stage IV, suggesting a correlation of decrease in NK activity with poor prognosis. We found efficient LAK activity against the NK-sensitive K562 cells and NK-resistant VIP (melanoma) and T-24 (bladder carcinoma) tumour targets in both low and normal NK responder HD patients, irrespective of the histopathological grade and clinical stage of the disease. In concordance with their good LAK cell activity, HD patients showed a frequency distribution of LAK cell progenitors in the PBL comparable to that of healthy donors. © The MacMillan Press Ltd., 1990.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 50 条
  • [1] NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL FUNCTIONS IN CHRONIC MYELOID-LEUKEMIA
    RAJARAM, N
    TATAKE, RJ
    ADVANI, SH
    NAIK, SL
    GANGAL, SG
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (01) : 44 - 48
  • [2] MODULATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL CYTOTOXICITY BY LACTOFERRIN
    SHAU, HY
    KIM, A
    GOLUB, SH
    JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (04) : 343 - 349
  • [3] EFFECT OF CHORIOCARCINOMA SUPERNATANT ON NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY
    FULOP, V
    SZIGETVARI, I
    SZEPESI, J
    GATI, I
    ACTA MEDICA HUNGARICA, 1993, 49 (3-4) : 239 - 247
  • [4] INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY OF NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    BERNSTEIN, ZP
    VAICKUS, L
    FRIEDMAN, N
    GOLDROSEN, MH
    WATANABE, H
    RAHMAN, R
    ARBUCK, SG
    SWEENEY, J
    VESPER, D
    HENDERSON, ED
    ZEFFREN, J
    DENNIN, RA
    LEVITT, D
    FOON, KA
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02): : 141 - 146
  • [5] INTERFERON ENHANCED NATURAL-KILLER FUNCTION IN HODGKINS-DISEASE
    LEVY, S
    REINS, F
    ALEKSIJEVIC, A
    GIRON, C
    OBERLING, F
    MAYER, S
    LANG, JM
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1986, 28 (05): : 323 - 325
  • [6] CHEMOTHERAPY-INDUCED MODULATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN EUTHYMIC AND ATHYMIC MICE
    GAZIT, Z
    KEDAR, E
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (04) : 243 - 252
  • [7] NORMAL NATURAL-KILLER CELL-ACTIVITY IN HODGKINS-DISEASE PATIENTS IN REMISSION
    DOUER, D
    SHAKED, N
    RAMOT, B
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 69 (03): : 660 - 667
  • [8] DIFFERENTIAL EFFECT OF CRYOPRESERVATION ON NATURAL-KILLER-CELL AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITIES
    MARTI, F
    MIRALLES, A
    PEIRO, M
    AMILL, B
    DEDALMASES, C
    PINOL, G
    RUEDA, F
    GARCIA, J
    TRANSFUSION, 1993, 33 (08) : 651 - 655
  • [9] NATURAL-KILLER CELL-ACTIVITY DURING THE COURSE OF DISEASE IN PATIENTS WITH HODGKINS-DISEASE
    FRYDECKA, I
    CANCER, 1985, 56 (12) : 2799 - 2803
  • [10] NATURAL-KILLER-CELL AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY AGAINST MELANOCYTES IN VITILIGO
    DURHAMPIERRE, DG
    WALTERS, CS
    HALDER, RM
    PHAM, HN
    VANDERPOOL, EA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (01) : 26 - 30